Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
September 4, 2023 9:46 amBorlaug BA […] Wolf D, Kosiborod MN. Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial. Nat Med 2023/29:2358-2365. doi: 10.1038/s41591-023-02526-x.
Categorised in:
This post was written by sfb1425
